Trial reportInternational journal of behavioral medicine2006
Effects of fasting therapy on irritable bowel syndrome.
Trial report in International journal of behavioral medicine, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 49 citations in OpenAlex.
- A 5Ad Dietary Protocol for Functional Bowel Disorders.Nutrients · 2019Trial
- Time-Restricted Eating and Symptom Severity in Irritable Bowel Syndrome: Results from a Pilot Study.Nutrients · 2026Article
- The relationship between night eating behavior, gastrointestinal symptoms, and psychological well-being: insights from a cross-sectional study in Türkiye.Journal of eating disorders · 2025Article
- Sensory Processing Sensitivity and Gastrointestinal Symptoms in Japanese Adults.International journal of environmental research and public health · 2022Article
- How Experiences Affect Psychological Responses During Supervised Fasting: A Preliminary Study.Frontiers in psychology · 2021Article
- Unravelling the health effects of fasting: a long road from obesity treatment to healthy life span increase and improved cognition.Annals of medicine · 2020Review
- N-Acetylglucosamine Inhibits LuxR, LasR and CviR Based Quorum Sensing Regulated Gene Expression Levels.Frontiers in microbiology · 2016Article
- Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation.World journal of gastroenterology · 2015Article
- Dietary Renaissance in IBS: Has Food Replaced Medications as a Primary Treatment Strategy?Current treatment options in gastroenterology · 2014Article
- Functional bowel symptoms, fibromyalgia and fatigue: a food-induced triad?Scandinavian journal of gastroenterology · 2012Article
- N-acetylglucosamine: production and applications.Marine drugs · 2010Review
- An Evidence-based Approach to Therapy in IBS-D: A Case Study Compendium.Gastroenterology & hepatology · 2010Article
- Blood-brain barrier disruption and edema formation due to prolonged starvation in wild-type mice.Brain circulationArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
How to treat patients with irritable bowel syndrome (IBS) who do not respond to pharmacotherapy is an unsolved problem. Psychotherapy, which has been reported on in previous studies, is available only in specific centers. We describe in this study a novel and simple psychotherapy; that is, the fasting therapy (FT) for treatment of patients with IBS. Of 84 inpatients with IBS, 58 patients who still had moderate to severe IBS symptoms after 4-week basic treatment were investigated retrospectively. Of the 58 patients enrolled in this study, 36 underwent FT, whereas the remaining 22 received a consecutive basic treatment (control therapy). There were no significant differences in the 4-point severity scales of gastrointestinal and psychological symptoms between the 2 groups before the start of FT. The basic treatment consisted of pharmacotherapy and brief psychotherapy, whereas the FT consisted of 10 days of starvation followed by 5 days of refeeding. Changes in scores of symptoms before and after each treatment were analyzed. FT significantly improved 7 out of the 10 symptoms assessed; that is, abdominal pain-discomfort (p < .001), abdominal distension (p < .001), diarrhea (p < .001), anorexia (p = .02), nausea (p < .01), anxiety (p < .001), and interference with life in general (p < .001). However, the control therapy significantly improved only 3 out of the 10 symptoms assessed; that is, abdominal pain-discomfort (p = .03), abdominal distension (p < .01), and interference with life (p = .01). Our results suggest that FT may have beneficial effects on intractable patients with IBS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.